Delivery Order SPE2DB22D1041-SPE2DB24FTZZ7
Award Date
2/28/24
Potential Completion Date
2/29/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $24,980.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under the DLA's Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies, including...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract is a delivery order valued at $10,145.18 for the supply of LOTREL 10-20 MG capsules. It is a firm fixed-price contract with a completion date of May 4, 2023. The contract is not designated as a set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,634.72 firm fixed-price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of July 25, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has significant Indefinite Delivery Contracts...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $15,309.96 firm-fixed-price delivery order is for the supply of Lotrel 10-20 mg capsules to support military healthcare programs. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The contract is for the delivery of Lotrel 5-20 mg capsules, a cardiovascular medication, with a ceiling value of $1,324.36 and a completion date of April 14, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,198.86 Firm Fixed Price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. This award is a part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen), valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lotrel 10-20 mg capsules. The $22,289.70 fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award, valued at $1,506.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product Lotrel 10-20 mg capsule, a medication used to treat high blood pressure. The contract has an ultimate completion date of December 11, 2023 and is a firm fixed-price arrangement. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The firm-fixed-price delivery order, valued at $2,349.59, has a completion date of June 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award, valued at $9,072.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lotrel 10-20 mg capsules to support military healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant Indefinite Delivery Contract (IDC) with...